Chief Executive Officer · Niagen Bioscience, Inc. (NAGE)

Robert Fried

A named executive officer of Niagen Bioscience in every fiscal year CompBrief holds from FY2017 to FY2025. Every figure below is printed as the company filed it and cited to the filing it came from.

Velarion Intel: free for 3 days, no card →

Total disclosed compensation, FY2025

$8,381,900

FY2024: $1,212,131

1st of 3 named executive officers at Niagen Bioscience by FY2025 total.

3 named officers on file for Niagen Bioscience, FY2025

See an example →

What this number hides

The filing gives the total. Niagen Bioscience’s full Executive Compensation Report gives every award, the disclosed peer set and what the total leaves out — the pair adds the board’s.

Compensation figures as of the proxy filed April 29, 2026 (DEF 14A).

Free

Get Robert Fried’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track Robert Fried and every company like it: Velarion Intel, free for 3 days, no card →

Robert Fried compensation by year

Niagen Bioscience Summary Compensation Table · all 9 fiscal years held
In US dollars, as Niagen Bioscience reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Salary$230,769$379,121$486,537$519,231$500,000$500,000$500,000$500,000$645,962
Bonus$163,945$468,330$190,404$0$0$0$0$0$0
Stock awards$2,539,999$1,255,003$653,331$0$0$0$0$0$5,220,188
Option awards$876,014$3,057,990$381,622$316,414$423,293$423,306$391,249$424,898$1,949,648
Non-equity incentive$0$0$0$290,304$179,131$234,808$268,221$286,497$565,378
Pension and deferred compensation$0$0$0$0$0$0$0$0$0
All other$0$0$0$736$736$736$736$736$724
Total$3,810,727$5,160,444$1,711,894$1,126,685$1,103,160$1,158,850$1,160,206$1,212,131$8,381,900

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Niagen Bioscience, Inc. DEF 14A filed April 29, 2026, accession 0001386570-26-000022, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Niagen Bioscience, Inc. filed document, accession 0001386570-26-000022. Every figure is read from that document and cited to the page and table it appears in. Filed April 29, 2026.

$3.8M
$5.2M
$1.7M
$1.1M
$1.1M
$1.2M
$1.2M
$1.2M
$8.4M
FY17
FY18
FY19
FY20
FY21
FY22
FY23
FY24
FY25
SalaryBonusNon-equity incentiveStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2025 year-end
TypeUnvested unitsValue at year-endExercise price
PSU1,518,600$5,220,188—
Option17,021—$1.82
Option155,388—$1.52
Option492,278—$5.48

Per the Outstanding Equity Awards at Fiscal Year-End table in Niagen Bioscience, Inc.'s FY2025 proxy; value at the fiscal year-end close, as the company printed it.

Change-in-control & termination

estimated payments Niagen Bioscience discloses, by trigger · FY2025
TriggerCash severanceAccelerated equityBenefits continuationTotal as disclosed
Involuntary termination without cause$975,000$986,646$11,923$1,973,569
Resignation for good reason, no change in control$975,000$986,646$11,923$1,973,569

Per the Potential Payments Upon Termination or Change in Control table in Niagen Bioscience, Inc.'s FY2025 proxy. Estimates as the company printed them; a dash means it printed no figure.

Niagen Bioscience’s named executive officers, FY2025

as the company reported each
Named executive officerRoleFY2025 total
Robert Fried · this pageChief Executive Officer$8,381,900
Ozan PamirChief Financial Officer$716,475
Carlos LopezSVP, General Counsel$558,014

Board service

Niagen Bioscience board · FY2021–FY2025

How this board is paid

Company policy: Niagen Bioscience pays directors a $40,000 cash retainer and $20,000 in Options. As stated in Niagen Bioscience's FY2025 proxy.

The full Niagen Bioscience compensation record

free company brief

This page is one person within Niagen Bioscience's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order Niagen Bioscience's full Executive Compensation Report with peer benchmarking.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Niagen Bioscience's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Order NAGE

Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

Robert Fried's compensation dossier